Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Cash from Operations (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Cash from Operations for 9 consecutive years, with 52469000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 24.16% to 52469000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 116976000.0 through Dec 2025, down 10.19% year-over-year, with the annual reading at 116976000.0 for FY2025, 10.19% down from the prior year.
  • Cash from Operations hit 52469000.0 in Q4 2025 for Inspire Medical Systems, down from 68526000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 69181000.0 in Q4 2024 to a low of 12748000.0 in Q1 2022.
  • Historically, Cash from Operations has averaged 13166250.0 across 5 years, with a median of 3161000.0 in 2023.
  • Biggest YoY gain for Cash from Operations was 3541.03% in 2025; the steepest drop was 175.65% in 2025.
  • Year by year, Cash from Operations stood at 734000.0 in 2021, then skyrocketed by 2525.2% to 19269000.0 in 2022, then fell by 10.39% to 17267000.0 in 2023, then surged by 300.65% to 69181000.0 in 2024, then decreased by 24.16% to 52469000.0 in 2025.
  • Business Quant data shows Cash from Operations for INSP at 52469000.0 in Q4 2025, 68526000.0 in Q3 2025, and 2684000.0 in Q2 2025.